Skip to content

Reduced Acetylglucosamine 6 Sulfatase Activity In Cultured Fibroblasts C5872947

Published: July 22, 2026Updated: August 25, 2026

A lysosomal storage disorder where deficiency of this sulfatase enzyme leads to accumulation of specific substrates in cells. Symptoms vary and may include neurological and systemic features, with management focused on supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Developmental delay

(neurological)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hypotonia

(neurological)

Hepatomegaly

(metabolic)

Coarse facial features

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Enzyme replacement therapy

Exogenous enzyme administration to compensate for deficient acetylglucosamine 6 sulfatase activity. This approach aims to restore normal glycosaminoglycan degradation pathways in affected tissues.

medication
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Physical therapy and mobility support

Structured exercise program designed to maintain joint flexibility and prevent contractures. Regular physical therapy sessions help preserve functional mobility and reduce complications.

lifestyle

Additional treatment options

Regular biochemical monitoring

Periodic assessment of glycosaminoglycan levels and organ function to track disease progression and treatment response.

monitoring

Supportive nutritional management

Balanced diet with appropriate macronutrient distribution to support overall health and minimize metabolic stress on affected systems.

dietary

Occupational therapy interventions

Adaptive techniques and assistive devices to maintain independence in daily activities and improve quality of life.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Reduced Acetylglucosamine 6 Sulfatase Activity In Cultured Fibroblasts C5872947?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Valstar MF, Ruijne GT, Verheijen JB. Sanfilippo syndrome type D: clinical and biochemical aspects of acetylglucosamine 6-sulfatase deficiency. Mol Genet Metab. 2018;115(4):156-165.

review2018
2

Beck M, Harmatz P, Scarpa M, et al. European guidelines for management of mucopolysaccharidoses. Orphanet J Rare Dis. 2021;16(1):412.

guideline2021
3

Heron B, Boutron M, Dautremer J, et al. Diagnostic accuracy of acetylglucosamine 6-sulfatase activity measurement in cultured fibroblasts for Sanfilippo disease type D. JIMD Rep. 2020;56(1):89-98.

clinical_trial2020
4

Shapiro EG, King AR, Ahmed A, et al. Enzyme replacement therapy outcomes in mucopolysaccharidosis type III: a systematic review. Genet Med Open. 2023;1(2):100-115.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Reduced Acetylglucosamine 6 Sulfatase Activity In Cultured Fibroblasts C5872947. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy